Nature Medicine·30 SepOral small-molecule GLP-1 receptor agonist safiglipron in early type 2 diabetes: a randomized, double-blind, placebo-controlled trialRandomised trial in 284 peopleType 2 diabetesPaper
Diabetes Care·24 AugA Randomized Placebo-Controlled Trial of HTD1801 Monotherapy in Participants With Type 2 DiabetesTrial in peopleInterventionsPaper